News Alert

Merck Extends its Conditions on 340B Pricing Involving Contract Pharmacies to Health Centers

Merck extended its restrictions on 340B pricing involving contract pharmacies to community health centers.

Drug manufacturer Merck today extended its restrictions on 340B pricing involving contract pharmacies to community health centers. The restrictions have applied only to hospital covered entities until now.

Other grantee covered entities remain exempt “at this time,” Merck

Read More »

340B Report Holding May 18 Webinar on Implementing Drug Makers’ New 340B Contract Pharmacy Rules

Multiple 340B covered entities and consultants say they have hit roadblocks trying to navigate drug manufacturers restrictions on 340B pricing when entities contract with outside pharmacies to dispense 340B drugs.

340B Report, an independent news organization covering the 340B drug pricing program, is holding its first event—a May 18 webinar about implementing drug manufacturers’ controversial new rules on 340B contract pharmacies. It is an exclusive

Read More »

Providers Alarmed About 45-Day Lookback Clauses in Drug Makers’ 340B Contract Pharmacy Policies

Covered entities are concerned about 45-day time limits for claims submissions and replenishment orders in drug manufacturers' 340B contract pharmacy policies.

Drug manufacturer Sanofi drew attention this month when it added 45-day time limits for replenishment orders and claims submissions to its conditions on 340B pricing when covered entities use contract pharmacies.

Pfizer and Amgen also recently added similar 45-day

Read More »

How 340B Works for People Living with HIV

SPONSORED CONTENT

At AIDS Healthcare Foundation, we commit to linking any person newly diagnosed with HIV to care within 72 hours of their reactive result. In addition, through our AHF Wellness Centers that offer free STI (Sexually Transmitted Infection) screening and testing, our Healthcare Centers, our Mobile Testing Units, and community events, we provide the public with several opportunities for STI testing.

If

Read More »

HIV/AIDS Clinics Tell FTC that PBMs Usurp 340B Discounts for Themselves

The "Man Controlling Trade" statute outside the FTC's Washington, D.C., headquarters. HIV/AIDS clinics recently submitted comments to the commission about PBMs' business practices.

Pharmacy benefit managers (PBMs) should be stopped from usurping 340B drug discounts from HIV/AIDS clinics and other safety-net providers, Ryan White Clinics for 340B Access (RWC-340B) told the U.S. Federal Trade Commission (FTC) last week.

RWC-340B asked the

Read More »

Notable Mis-Quotables: Setting Organizational Policy When the Statute is Silent

SPONSORED CONTENT

As with so many other things in life, the 340B program has its own elements that have moved from practice, to accepted principles, to perceived law. This may be because we by nature want the program to be clearly and explicitly defined to prevent inadvertent and unintentional compliance errors. Fortunately, and sometimes unfortunately, the program has

Read More »

With Retired Sen. Hatch’s Passing, a Legendary 340B Tale is Told

Retired U.S. Sen. Orrin Hatch (R-Utah), who died this weekend, played a key role in 340B's creation and development.

Retired U.S. Sen. Orrin Hatch of Utah, a conservative Republican icon who helped create and shape the 340B drug pricing program, has died. He was 88.

Hatch personally was responsible for choosing one of the 340B program’s most

Read More »

Federal Circuit Court Begins Lilly’s 340B Contract Pharmacy Lawsuit Appeal in Earnest

The U.S. Seventh Circuit Court of Appeals issued a schedule for the filing of briefs in Lilly's 340B contract pharmacy lawsuit.

A federal appeals court in Chicago is satisfied with the final judgement it ordered a lower court to issue in Lilly’s 340B contract pharmacy lawsuit, clearing the way the lawsuit’s next stage to get rolling.

The U.S. Seventh

Read More »

Influential HIV/AIDS Group Asks Gilead to Exempt Ryan White Clinics from Company’s 340B Contract Pharmacy Restrictions

RWC-340B asked Gilead to exempt all Ryan White clinics from the company’s conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.

Ryan White Clinics for 340B Access (RWC-340B) has asked drug manufacturer Gilead to exempt all Ryan White clinics from the company’s conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.

RWC-340B

Read More »

73 Groups Want Congress to Enact Major Drug Pricing Reforms by Memorial Day

Seventy three organizations, under the banner Push for LowerRx Prices, launched a campaign to press Congress to pass comprehensive Democratic drug pricing legislation by Memorial Day.

More than 70 groups representing patients, healthcare professionals, consumers, retirees, employers, and unions launched a campaign this morning to get comprehensive Democratic drug pricing legislation signed into law by Memorial Day.

It is premature to guess how the

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors